{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Hu Y"],"pubmed_abstract":["<h4>Background</h4>Rheumatic heart disease (RHD) remains the leading cause of preventable death and disability in children and young adults, killing an estimated 320,000 individuals worldwide yearly.<h4>Materials and methods</h4>We utilized the Bayesian age-period cohort (BAPC) model to project the change in disease burden from 2020 to 2030 using the data from the Global Burden of Disease (GBD) Study 2019. Then we described the projected epidemiological characteristics of RHD by region, sex, and age.<h4>Results</h4>The global age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) of RHD increased from 1990 to 2019, and ASPR will increase to 559.88 per 100,000 population by 2030. The global age-standardized mortality rate (ASMR) of RHD will continue declining, wh"],"journal":["Frontiers in cardiovascular medicine"],"pagination":["941917"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622772"],"repository":["biostudies-literature"],"pubmed_title":["The projections of global and regional rheumatic heart disease burden from 2020 to 2030."],"pmcid":["PMC9622772"],"pubmed_authors":["Li H","Hu Y","Huang X","She ZG","Tong Z","Qin JJ","Lei F","Sun T","Cai J","Wang W","Lin L","Liu W"],"additional_accession":[]},"is_claimable":false,"name":"The projections of global and regional rheumatic heart disease burden from 2020 to 2030.","description":"<h4>Background</h4>Rheumatic heart disease (RHD) remains the leading cause of preventable death and disability in children and young adults, killing an estimated 320,000 individuals worldwide yearly.<h4>Materials and methods</h4>We utilized the Bayesian age-period cohort (BAPC) model to project the change in disease burden from 2020 to 2030 using the data from the Global Burden of Disease (GBD) Study 2019. Then we described the projected epidemiological characteristics of RHD by region, sex, and age.<h4>Results</h4>The global age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) of RHD increased from 1990 to 2019, and ASPR will increase to 559.88 per 100,000 population by 2030. The global age-standardized mortality rate (ASMR) of RHD will continue declining, wh","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T02:38:30.335Z","creation":"2025-04-07T13:02:39.615Z"},"accession":"S-EPMC9622772","cross_references":{"pubmed":["36330016"],"doi":["10.3389/fcvm.2022.941917"]}}